Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells

Front Oncol. 2021 Apr 8:11:668460. doi: 10.3389/fonc.2021.668460. eCollection 2021.

¹ Department of Experimental, Diagnostic and Specialty Medicine, Policlinico S. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy.
² Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy.
³ Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
⁴ Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy.
⁵ Laboratory of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy.
⁶ Department of Haematology, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute University of Cambridge, Cambridge, United Kingdom.
⁷ Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
⁸ Department of Oncology and Hematology, Institute of Hematology "L. and A. Seràgnoli", University-Hospital S.Orsola-Malpighi, Bologna, Italy.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.01225.].

Keywords: acute myeloid leukemia; bitter compounds; bitter taste receptors; bone marrow microenvironment; denatonium benzoate.